ZYUS Life Sciences Corporation
ZLSCF
$0.01
-$0.03-65.75%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.20M | -2.63M | -3.20M | -3.20M | -2.76M |
| Total Depreciation and Amortization | 124.40K | 524.90K | 488.60K | 488.60K | 483.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 512.70K | 310.70K | 451.00K | 451.00K | 374.20K |
| Change in Net Operating Assets | 564.50K | -34.90K | 847.80K | 847.80K | -71.80K |
| Cash from Operations | -1.00M | -1.83M | -1.41M | -1.41M | -1.97M |
| Capital Expenditure | -- | -6.50K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 18.10K | 18.10K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -6.50K | 18.10K | 18.10K | -- |
| Total Debt Issued | 1.43M | 2.38M | 1.91M | 1.91M | 1.75M |
| Total Debt Repaid | -155.00K | -50.00K | -89.00K | -89.00K | -158.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 917.60K | 1.69M | 1.32M | 1.32M | 1.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.70K | -143.80K | -75.20K | -75.20K | -863.30K |